2012

Dr. Tine Jess member of the Young Academy of the Royal Danish Academy of Sciences

30 November 2012

We are proud to announce that Dr. Tine Jess has been elected as one of 8 new members in year 2012 of the Young Academy of the Royal Danish Academy of Sciences.

Sudden cardiac death: Relatives at risk for cardiovascular disease

16 November 2012

Relatives of young people who have died suddenly from a heart-related problem are at greatly increased risk of developing cardiovascular disease (CVD) according to a Danish study published online in the European Heart Journal.

Study finds no link between quit-smoking drug varenicline and suspected cardiovascular adverse events

14 November 2012

Smoking represents the number one preventable cause of mortality worldwide. Any effective smoking cessation aid may accordingly have important impact by reducing mortality and the burden of smoking associated disease. Varenicline, introduced in 2006, has proven efficacious for smoking cessation and rapidly become a commonly used drug. Recent studies have, however, raised concerns that varenicline may increase the risk of serious cardiovascular events.

Early-onset cardiovascular disease runs in the family

21 August 2012

Having a relative die of cardiovascular causes before 60 years of age doubles a person’s risk of early-onset cardiovascular disease. As the number of early deaths in the family increases and age at death decreases, risk increases by up to 10-fold. Researchers suggest family history is considered when evaluating a young person’s risk for cardio­vascular disease

Decreasing risk of colorectal cancer in patients with inflammatory bowel disease

9 July 2012

The risk of colorectal cancer has decreased markedly among patients with ulcerative colitis over the past 30 years according to a nationwide Danish study of 47,374 patients with inflammatory bowel disease. The study is newly published in Gastroenterology, the highest ranking journal in the field. The study was conducted by researchers from the Department of Epidemiology Research at Statens Serum Institut in Denmark.

Pandemic flu vaccine in pregnancy did not cause pregnancy loss

2 May 2012

There is no evidence of increased risk of fetal death following vaccination against the 2009 pandemic flu strain in pregnancy. This is the conclusion of a nationwide cohort study of more than 50,000 pregnant women in Denmark. The study was conducted by Danish researchers from the Department of Epidemiology Research, Statens Serum Institut, and published in the prestigious British Medical Journal.

Antihypertensive medication shows promise in the treatment of Parkinson's disease

19 April 2012

A group of commonly used antihypertensives, the so-called calcium-channel blockers, shows promise in the treatment of Parkinson’s disease in a large Danish register-based study. The study is newly published in the well-respected American Journal of Epidemiology, and was conducted by researchers from the Department of Epidemiology Research located at Statens Serum Institut in Denmark.

Three genetic variants found for common digestive system disorder in newborns

13 February 2012
Researchers at Statens Serum Institut have conducted a large genome-wide association study of infantile hypertrophic pyloric stenosis, and report the association of three single nucleotide polymorphisms (SNPs) with the disease. The SNPs are located close to genes otherwise known to play a role in muscular dystrophy and congenital heart defects. The results of the study have just been published online ahead of print in Nature Genetics.

Study confirms suspicion of different variants of Hodgkin lymphoma

10 February 2012
An international scientific study including Danish scientists, published this week in Journal of the National Cancer Institute, confirms the long-held suspicion that different variants of Hodgkin lymphoma exist. This knowledge may be crucial to future studies of the causes and course of the disease. The study results have already prompted new collaboration across country borders.

Genetic differences helps to explain why Europeans experience higher malaria mortality than Africans

26 January 2012

It has long been known that ethnic Europeans have a much higher risk of dying from serious malaria infection than ethnic Africans. New research from SSI shows that Europeans have up to 75% greater risk of developing cerebral malaria than Africans, and the reasons are genetic.

R and D News

Search in R & D news: